A NETWORK META-ANALYSIS OF FIRST-LINE SYSTEMIC THERAPIES FOR ADVANCED HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Singh, B. [1 ]
Sharma, A. [1 ]
Rai, P. [1 ]
Kaur, G. [1 ]
Pandey, S. [1 ]
机构：
[1] Pharmacoevidence, Sas Nagar Mohali, PB, India
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO67
引用
收藏
页码：S26 / S26
页数：1
相关论文
共 50 条
  • [21] First-line treatments for advanced hepatocellular carcinoma: a network meta-analysis and cost-effectiveness analysis in China and the United States
    Sun, Ke-Xin
    Cao, Shan-Shan
    Shi, Feng-Hao
    Guan, Yue
    Tang, Meng
    Zhao, Mei-na
    Jian, Yu-Fan
    Cui, Bin
    Li, Zhi-Yan
    Wang, Jing-Wen
    Yu, Feng
    Ding, Yi
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [22] Efficacy of First Line Systemic Chemotherapy and Multikinase Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis
    Oranratnachai, Songporn
    Rattanasiri, Sasivimol
    Pooprasert, Anantaporn
    Tansawet, Amarit
    Reungwetwattana, Thanyanan
    Attia, John
    Thakkinstian, Ammarin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [23] Efficacy and Safety of Systemic Therapies for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis of Phase III Trials
    Cucchetti, Alessandro
    Piscaglia, Fabio
    Pinna, Antonio Daniele
    Djulbegovic, Benjamin
    Mazzotti, Federico
    Bolondi, Luigi
    LIVER CANCER, 2017, 6 (04) : 337 - 348
  • [24] First-line systemic therapy for advanced gastric cancer: a systematic review and network meta-analysis
    Cheng, Ji
    Cai, Ming
    Shuai, Xiaoming
    Gao, Jinbo
    Wang, Guobin
    Tao, Kaixiong
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [25] First-line targ veted therapies of advanced hepatocellular carcinoma: A Bayesian network analysis of randomized controlled trials
    Ding, Wei
    Tan, Yulin
    Qian, Yan
    Xue, Wenbo
    Wang, Yibo
    Jiang, Peng
    Xu, Xuezhong
    PLOS ONE, 2020, 15 (03):
  • [26] The Impact of Sequential Therapies after First-Line Systemic Therapies in Unresectable Hepatocellular Carcinoma
    Lee, Shou-Wu
    Lee, Teng-Yu
    Yang, Sheng-Shun
    Huang, Yi-Jie
    Peng, Yen-Chun
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (09)
  • [27] First-Line Systemic Treatment Strategies for Unresectable Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials
    Liu, Wenfeng
    Quan, Bing
    Lu, Shenxin
    Tang, Bei
    Li, Miao
    Chen, Rongxin
    Ren, Zhenggang
    Yin, Xin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [28] Targeted first-line therapies for advanced colorectal cancer: a Bayesian meta-analysis
    Ridouane, Yassine
    Lopes, Gilberto
    Ku, Geoffrey
    Masud, Hasan
    Haaland, Benjamin
    ONCOTARGET, 2017, 8 (39) : 66458 - 66466
  • [29] Efficacy and safety of lenvatinib versus sorafenib in first-line treatment of advanced hepatocellular carcinoma: A meta-analysis
    Luo, Jia
    Gao, Benjian
    Lin, Zhiyu
    Fan, Hua
    Ma, Wen
    Yu, Danfei
    Yang, Qian
    Tian, Jing
    Yang, Xiaoli
    Li, Bo
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [30] Lenvatinib versus sorafenib as first-line therapy of advanced hepatocellular carcinoma: a systematic review and meta-analysis
    Facciorusso, Antonio
    Tartaglia, Nicola
    Villani, Rosanna
    Serviddio, Gaetano
    Ramai, Daryl
    Mohan, Babu P.
    Chandan, Saurabh
    Abd El Aziz, Mohamed A.
    Evangelista, Jessica
    Cotsoglou, Christian
    Ambrosi, Antonio
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (04): : 2379 - 2387
12345